Uganda Country Profile

Uganda Country Profile

Discover more about CDC’s work in Uganda by viewing our detailed country profilepdf icon

Country Overview

While its work in Uganda dates back to 1991, CDC established its office there in 2000 and continues to work with the Ministry of Health to provide high-quality HIV prevention and treatment services. Providing both funding and technical assistance, CDC employs a service-delivery model integrated with national, regional, and district structures within Uganda to build the capacity of its heavily burdened public health system to respond to both HIV and tuberculosis (TB). CDC supports Uganda’s efforts to find more persons living with HIV, expand antiretroviral treatment (ART) to all HIV-positive Ugandans immediately upon diagnosis, and scale up viral load testing. In addition, CDC supports the integration of TB services into existing prevention of mother-to-child transmission and ART services, TB preventive treatment, HIV testing, and linkage to HIV ART for TB/HIV co-infected clients.

Per Capita GNI

$630

(2016)

Population (million)

41.49

(2016)

Under 5 Mortality

53/1000 Live Births

(2016)

Life Expectancy

60

(2016)

Estimated HIV Prevalence

6.5%

(Ages 15-49): (2016)

Estimated AIDS Deaths

23,000

(2016)

TB Treatment Success Rate

75%

(2015)

Estimated TB Incidence

201/100,000

(2016)

Estimated Orphans Due to AIDS

970,000

(2017)

TB patients with known HIV-status who are HIV-positive

43%

(2016)

Reported Number Receiving Antiretroviral Therapy (ART)

876,000

(2016)


Strategic Focus

The Centers for Disease Control and Prevention (CDC) works with the Uganda Ministry of Health (MoH) and other stakeholders to provide high-quality HIV prevention,  and treatment services through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). CDC provides technical assistance, uses a service-delivery model integrated with national, regional and district structures to build capacity of the heavily burdened public health system to respond to HIV and tuberculosis (TB).

Strengthening National Public Health Systems: With a focus on a uniformly coordinated, nationally owned laboratory network that effectively responds to the country’s diagnostic needs, CDC supports infrastructure development and equipment maintenance to ensure uninterrupted service delivery. CDC also supports public health workforce development and staffing; procurement and supply chain strengthening to improve access to HIV/AIDS medicines and related commodities across the country through private not-for-profit facilities; information and management systems; monitoring and evaluation; operations research; and other health priorities.

Supporting HIV epidemic control efforts: As one of 13 PEPFAR countries selected for the Accelerating HIV/AIDS Epidemic Control (2017-2020) Strategy, CDC supports Uganda’s efforts to find more persons living with HIV by testing those most at risk; expanding Antiretroviral treatment (ART) offer to all HIV-positive Ugandans immediately upon diagnosis ─ irrespective of disease staging or CD4 cell count; and scaling up viral load (VL) testing to monitor for HIV suppression. CDC also supports reduction of new HIV infections through the Prevention of Mother to Child HIV Transmission (PMTCT) program, the PEPFAR Determined Resilient Empowered AIDS-free Mentored Safe (DREAMS) program, roll out of pre-exposure prophylaxis (PrEP), stronger key population programs, and Voluntary Medical Male Circumcision (VMMC).

Strengthening TB and HIV integrated services: CDC supports TB diagnosis including Multi-Drug Resistant (MDR) TB, through systematic TB screening for clients attending HIV clinics, increased access to and utilization of GeneXpert MTB/RIF, strengthening of the sample referral system, and quality assurance for TB diagnostics.   A greater focus on pediatric TB diagnosis has improved case-finding as well as treatment. In addition, CDC supports the integration of TB services into existing PMTCT/ART services, TB preventive treatment (TPT), HIV testing, and linkage to HIV ART for TB/HIV co-infected clients.

Key Activities and Accomplishments

HIV Prevention: CDC is employing successful models to improve access to HIV and TB services for key and priority populations amidst an improved, enabling policy and legal environment. Additionally, CDC continues to support a strong PMTCT program and to measure efforts towards elimination through a national impact evaluation and the largest VMMC program in the world.

HIV Treatment: CDC supports HIV treatment in Uganda by providing ART for HIV positive individuals and promoting adherence to increase the number of HIV positive individuals who are virally suppressed.  CDC works to ensure adoption of optimized ART regimens for adults and children CDC links participants to available household economic strengthening and education programs to support HIV infected and affected orphans, vulnerable children, and their families.

Human Resources for Health: CDC supports national health workforce development through direct staff recruitment and on-site mentorship.

TB/HIV Services: CDC provides ART to over half of the TB/HIV co-infected clients supported by PEPFAR. CDC also supports TB preventive treatment (TPT) scale up and use of better diagnostic tests, including GeneXpert MTB/RIF and Urine LAM. CDC is also working with other partners on improving contact tracing with hopes to integrate TB and HIV screening, diagnosis, and treatment where possible.

Laboratory systems strengthening: CDC supported construction of the Uganda National Health Laboratory Services (UNHLS) ─ for centralized testing for HIV-VL and monitoring quality of diagnostic services ─ including  supporting the Early Infant Diagnosis-VL lab to attain international accreditation through South African National Accreditation System (SANAS), thus ensuring accurate and reliable results. Additionally, UNHLS developed an e-results download module and implemented it in the 100 hub labs which has ensured real-time download of results for proper patient management.


The Hidden Epidemic: TB Among Children

More than 1 million children annually – from India to Indiana, Botswana to Brazil — become sick from this disease. Although children under the age of 15 are among those most vulnerable, most diagnostic tests for TB are unable to identify their disease; most available treatments are ineffective for younger victims; and an estimated 20 percent of all children with TB disease will die.

Five African Countries Approaching Control of Their HIV Epidemics

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC, and ICAP at Columbia University released today new findings from Population-based HIV Impact Assessments (PHIA) showing significant progress against HIV epidemics.

For One Mother, PEPFAR Helped Prevent Transmission of HIV to Her 10 Children

Nanjala Madina is an HIV-positive mother of 10 children who makes a living selling vegetables along the streets of her working-class neighborhood in Kampala. She learned her HIV positive status in 2002 when health workers from Reach Out Mbuya Parish HIV/AIDS Initiative (ROM) came to her neighborhood for community HIV sensitization. “I had four children then,” she recalls.

Namulindwa Rose: 15 Years of PEPFAR Care and Still Patient 0001

Namulindwa Rose lost her husband to AIDS in 2000—though she had no idea at the time that this was the cause. “I was devastated; I had spent a month taking care of him in Nsambya Hospital (in Uganda’s capital, Kampala),” Rose recalls. “Then, when I learned that he had died of AIDS, I was advised to test for HIV at Nsambya Home Care (NHC).” The test came back positive for HIV. “It was overwhelming,” Rose says. “I actually became mentally ill.”

Combating the Global TB Epidemic

Despite being preventable and treatable, tuberculosis (TB) is now the leading infectious disease killer in the world, taking the lives of 1.6 million people each year.

PEPFAR15 – Saving lives through American generosity and partnerships

For fifteen years, CDC has played a critical role in PEPFAR’s efforts to save millions of lives and transform the global HIV/AIDS response

Page last reviewed: May 22, 2019, 12:55 PM